🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to message these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Content Elimination

According to the social media company, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the service safe and investing in strengthening compliance measures.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at residence.

Within minutes of joining one group, a vendor posted contact information, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.

Product Information and Costs

Inside these groups, messages show dark colored parcels with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has already seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to possibly serious health risks”.